SCA & ARCA Global Conference 2020, 19-21 October 2020

SCA Global is a worldwide initiative for clinical research in spinocerebellar ataxias. Redenlab founder Adam Vogel will be presenting “Speech as a biomarker in ataxia: What can it tell us and how should we use it?”

Click here to learn more or register.

Related Post

  • Posted on 15 September, 2021
    Redenlab are presenting some of their work on Parkinson’s Disease and speech at the upcoming virtual Movement Disorders Society Conference...
    • Posted on 14 September, 2021
      Over the past two decades, genomic studies have played an increasingly important role in exploring the history of our own...
      • Posted on 31 May, 2021
        Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or...